Company overview
Creative Peptides is a CDMO specializing in high-quality peptide synthesis, modification, conjugation, and cGMP manufacturing for pharmaceutical and biotech applications. They offer custom peptide services from research-scale to large-scale production, including peptide libraries, analysis, and bioactive products supporting drug discovery and clinical development. With expertise in solid-phase and solution-phase synthesis, they serve global clients in peptide drug research, immunotherapy, and cosmetics.
Creative Peptides is listed in the NovaPharmaNews Supplier Hub as a CDMO & Manufacturing partner serving United States & Americas. Core focus areas include peptide synthesis, custom peptides, cgmp peptides, peptide cdmo, peptide modification.
Industry categories: CDMO & Manufacturing. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Structured facts
- Website
- https://www.creative-peptides.com
- Categories
- CDMO & Manufacturing
- Markets served
- United States & Americas
- Keywords
- peptide synthesis, custom peptides, cgmp peptides, peptide cdmo, peptide modification
Products & technologies
Therapeutic areas
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What peptide synthesis capabilities does Creative Peptides offer?
- Custom peptide synthesis from small-scale research to large-scale cGMP production, using Boc/Fmoc solid-phase and solution-phase methods, with modifications like phosphorylation, glycosylation, and lipidation.
- Does Creative Peptides comply with regulatory standards for pharma?
- Yes, they provide cGMP-compliant manufacturing and process development for clinical applications, ensuring high purity, consistency, and regulatory compliance.
- What geographies does Creative Peptides serve?
- Based in New York, USA, they deliver tailored peptide solutions worldwide to pharmaceutical, biotechnology, and research partners.
Related editorial coverage
- CordenPharma Expands Production Capacity with New CDMO Deal
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
Explore lab tools and QA/QC resources for R&D teams.
